Streetbeat News

Price Targets

ZTS

BTIG initiates coverage on Zoetis (NYSE:ZTS) with a Buy rating and sets a price target of $220.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:55 am

MXL

Benchmark analyst David Williams maintains a Buy rating on MaxLinear (NASDAQ:MXL) but lowers the price target from $28 to $22.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:53 am

EVR

Goldman Sachs analyst James Yaro maintains a Neutral rating on Evercore (NYSE: EVR) and raises the price target from $223 to $251.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:51 am

AVY

UBS analyst Joshua Spector has downgraded Avery Dennison (NYSE:AVY) from Buy to Neutral and lowered the price target from $262 to $235.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:50 am

EW

B of A Securities has downgraded Edwards Lifesciences (NYSE:EW) from Buy to Neutral and lowered the price target from $105 to $75.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:49 am

LULU

Citigroup analyst Paul Lejuez has downgraded Lululemon Athletica from Buy to Neutral and lowered the price target from $415 to $300.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:47 am

SIRI

Citigroup analyst Jason Bazinet has downgraded Sirius XM Holdings (NASDAQ:SIRI) from Neutral to Sell and set a price target of $2.8.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:46 am

BIRK

B of A Securities has upgraded Birkenstock Holding (NYSE:BIRK) from Neutral to Buy and raised the price target from $62 to $65.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:46 am

CATX

B of A Securities has initiated coverage on Perspective Therapeutics (AMEX:CATX) with a Buy rating and set a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:44 am

CME

Piper Sandler analyst Patrick Moley maintains an Overweight rating on CME Group (NASDAQ:CME) but lowers the price target from $235 to $225.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 11:44 am